Clark-Snustad, Kindra Dawn
Singla, Anand
Lee, Scott David
Article History
Received: 5 December 2018
Accepted: 22 January 2019
First Online: 28 February 2019
Compliance with ethical standards
:
: This study did not receive specific funding. Lee SD received grant and research support from the following: AbbVie Pharmaceuticals, UCB Pharma, Janssen Pharmaceuticals, Inc., Salix Pharmaceuticals, Takeda Pharmaceuticals, Inc., Celgene Pharmaceuticals, Inc., Pfizer Pharmaceuticals, Inc., Atlantic Pharmaceuticals, Ltd., Gilead Sciences, Inc., Tetherex Pharmaceuticals, Arena Pharmaceuticals, Shield Therapeutics PLC and is a consultant for UCB Pharma, Mesoblast, Cornerstones, Janssen Pharmaceuticals, Inc., Takeda Pharmaceuticals, Inc., Arena Pharmaceuticals, Eli Lilly and Company, Celgene Pharmaceuticals, Inc., Celltrion Healthcare Co, Ltd, Pfizer Pharmaceuticals, Salix Pharmaceuticals. Clark-Snustad KD has been a consultant for Takeda Pharmaceuticals, Inc. For the remaining authors, no conflicts of interest were declared.